Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease

Eye (Basingstoke)

Volumn 28, Issue 6, 2014, Pages 680-690

  Polo, V ^a,b   Garcia Martin, E ^a,b   Bambo, M P ^a,b   Pinilla, J ^a,b   Larrosa, J M ^a,b   Satue, M ^a,b   Otin, S ^a,b   Pablo, L E ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLAUCOMA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RELIABILITY; RETINA ATROPHY; RETINA DISEASE; RETINA NERVE FIBRE LAYER ATROPHY; RETINAL THICKNESS; VALIDITY;

EID: 84928772609     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.51     Document Type: Article

References (38)

1. Georges J. Giving a voice to people with dementia. Dementia in Europe: The Alzheimer Europe Magazine 2012; 4: 1.
2. Wimo A, Winblad B, Jonsson L. The worldwide societal costs of dementia: estimates for 2009. Alzheimers Dement 2010; 6(2): 98-103.
3. Sadun AA, Borchert M, De Vita E, Hinton DR, Bassi CJ. Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol 1987; 104: 113-120.
4. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosc 1987; 7: 1799-1808.
5. Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comp Neurol 1990; 301: 55-64.
6. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48(5): 2285-2289.
7. Iseri PK, Altinaş O, Tokay T, Yu ksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmol 2006; 26(1): 18-24.
8. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 2011; 113(7): 523-526.
9. Schuman JS, Pedut-Kloizman T, Hertzmark E, Hee MR, Wilkins JR, Coker JG et al. Reproducibility of nerve fibre layer thickness measurements using optical coherence tomography. Ophthalmology 1996; 103(11): 1889-1898.
10. Garcia-Martin E, Rodriguez-Mena D, Herrero R, Almarcegui C, Dolz I, Martin J et al. Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS. Neurology 2013; 81(1): 76-83.
11. Garcia-Martin E, Satue M, Fuertes I, Otin S, Alarcia R, Herrero R et al. Ability and reproducibility of Fourierdomain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 2012; 119(10): 2161-2167.
12. Valenti DA. Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease. Int J Alzheimers 2011; 2010: 793931.
13. Garcia-Martin E, Pablo LE, Herrero R, Satue M, Polo V, Larrosa JM et al. Diagnostic ability of a linear discriminant function for Spectral domain optical coherence tomography in multiple sclerosis patients. Ophthalmology 2012; 119(8): 1705-1711.
14. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73: 302-308.
15. Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol 2010; 4: 1427-1432.
16. Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients. Eye 2013; 27(4): 507-514.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. American Psychiatric Association: Washington, DC, USA, 1994.
19. Gupta PK, Asrani S, Freedman SF, El-Dairi M, Bhatti MT. Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography. Open Neurol J 2011; 5: 1-7.
20. Wu Z, Huang J, Dustin L, Sadda SR. Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma 2009; 18: 213-216.
21. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1. 1985; 103: 1796-1806.
22. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State Examination: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
23. Rebok G, Brandt J, Folstein M. Longitudinal cognitive decline in patients with Alzheimer's disease. J Geriat Psychiat Neurol 1990; 3: 91-97.
24. Garcia-Martin E, Pueyo V, Pinilla I, Ara JR, Martin J, Fernandez J. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy. Invest Ophthalmol Vis Sci 2011; 52: 4124-4131.
25. Parikh RS, Parikh SR, Sekhar GC, Prabakaran S, Babu JG, Thomas R. Normal age-related decay of retinal nerve fiber layer thickness. Ophthalmology 2007; 114: 921-926.
26. Garcia-Martin E, Pueyo V, Almarcegui C, Martin J, Ara JR, Sancho E. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 2011; 95: 1577-1582.
27. Vizzeri G, Balasubramanian M, Bowd C, Weinreb RN, Medeiros FA, Zangwill LM. Spectral domain-optical coherence tomography to detect localized retinal nerve fiber layer defects in glaucomatous eyes. Opt Express 2009; 17: 4004-4018.
28. Armstrong RA. Visual field defects in Alzheimeŕs disease patients may reflect differential pathology in the primary visual cortex. Optom Vis Sci 1996; 73: 677-682.
29. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996; 17: 377-384.
30. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimeŕs disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 1996; 17: 385-395.
31. Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimeŕs disease dementia. Trends Neurosci 2011; 34(8): 430-442.
32. Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603-1609.
33. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007; 69: 2085-2092.
34. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44: 2793-2797.
35. Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong JR et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008; 268: 12-17.
36. Fortune B, Cull GA, Burgoyne CF. Relative course of retinal nerve fiber layer birefringence and thickness and retinal function changes after optic nerve transection. Invest Ophthalmol Vis Sci 2008; 49: 4444-4452.
37. Knight OJ, Chang RT, Feuer WJ, Budenz DL. Comparison of retinal nerve fiber layer measurements using time domain and spectral domain optical coherent tomography. Ophthalmology 2009; 116: 1271-1277.
38. Leung CK, Cheung CY,Weinreb RN, Qiu Q, Liu S, Li H et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology 2009; 116: 1257-1263.